RPE65 and retinal disorder: There is now an approved retinal gene therapy for autosomalrecessive RPE65-retinopathy, and numerous oculargene/mutation-targeted clinical trials underway, highlighting the importance ofestablishing a genetic diagnosis so patients can fully access the latestresearch developments and treatment options.